The regulatory mechanism of NLRP3 inflammasome in the “immune paralytic-overactivation” imbalance in sepsis: the latest progress from molecular signaling to clinical translation - Top-Institutions - MDSpire

The regulatory mechanism of NLRP3 inflammasome in the “immune paralytic-overactivation” imbalance in sepsis: the latest progress from molecular signaling to clinical translation

  • By

  • Gaosheng Zhou

  • Yifei Chen

  • Dingdeng Wang

  • Yixin Cheng

  • Zhaohui Zhang

  • April 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Immunology
    • Critical Care Medicine
    • Molecular Biology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Immunology
    • Infectious Diseases
    • Critical Care

  • #3

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Immunology
    • Critical Care Medicine
    • Molecular Medicine

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Immunology
    • Critical Care Medicine
    • Translational Research

  • #5

    Washington University in St. Louis
    Washington University in St. Louis

    St. Louis, MO

    Key Differentiators

    • Immunology
    • Critical Care Medicine
    • Molecular Biology

Original Source(s)

The regulatory mechanism of NLRP3 inflammasome in the “immune paralytic-overactivation” imbalance in sepsis: the latest progress from molecular signaling to clinical translation

  • by Gaosheng Zhou, Yifei Chen, Dingdeng Wang, Yixin Cheng, Zhaohui Zhang

  • April 30, 2026

Related Content

Efficacy analysis of disitamab vedotin (RC-48) in the treatment of HER2-low metastatic breast cancer: a case report

How to Perform Device-Free, Free-Handed Transperineal Prostate Biopsy

Fox Chase Cancer Center’s urologic oncology group shares an educational video that provides instruction on how to perform a device-free, free-handed transperineal prostate biopsy.

  • September 16, 2021

  • 2 min
Major systemic infection following breast cancer surgery and oncological outcomes